This article was AI-generated as part of an experimental historical-content project. The date reflects the period being analyzed rather than the date the article was originally written.
Nestlé’s first-quarter sales release this morning puts a number on the infant formula recall. The company launched a global precautionary recall in January, after detecting cereulide, which it says was caused by an ingredient from a global industry supplier. That followed a smaller precautionary recall in several European markets in December. Nestlé now says the recall cost about 90 basis points of organic growth in the quarter. Reported organic growth was 3.5%, and the company kept its 2026 guidance of around 3% up to 4%.
The more interesting part is how the 90 basis points break down. About half, the release says, was “the direct effect of sales returns, temporary stock shortages and subsequent replenishment.” The remainder “was driven by the impact on consumer demand.”
That is an unusually clean split, and it reads well as a finance document about reputation.
Two kinds of cost
The first half is logistics. Products came back, shelves emptied, shelves were refilled. Nestlé says “product availability is now back to normal.” That cost is finite, and it ends when the supply chain recovers.
The second half is parents choosing not to buy. In his prepared remarks for the investor call, chief executive Philipp Navratil said infant formula sales were “currently down around 10% or so due to consumer impact,” and that teams had been engaging with healthcare professionals, retailers and consumers “to rebuild trust in our brands.” Nestlé expects to “fully recover by the end of the year,” and points to a structural feature of the category: new parents enter it every day.
So one event has produced, within one quarter, a cost that has been fixed and a cost that is still running. The release describes the first in the past tense and the second in the future tense.
Why the second half lives online
A company can restore supply. Demand comes back when parents decide the product is safe again, and much of that decision now happens through a search box, a parenting forum, or an assistant. What they find is the record built since December: recall notices from food safety agencies in many countries and languages, news coverage of cereulide, and threads from worried parents.
None of that updates when the shelves are restocked. A regulator’s recall notice does not get a footer saying availability is normal. January’s news stories remain prominent results for a brand name plus “recall.” An AI summary of whether a formula is safe will draw on those sources unless something newer and equally authoritative exists.
That is why “back to normal operations” and “back to normal in search” run on different clocks. Investor relations can report the first. The second helps decide whether the consumer-demand half of the 90 basis points closes on the schedule the company has set.
What investors and IR teams can take from it
The split is a useful template for any company recovering from a product crisis. Separate the operational cost from the trust cost and track them separately. The first has a known end. The second depends partly on what the public record says, which the company influences but does not control.
For communications teams, that means the recovery needs its own public record: dated updates stating what was found, what was fixed and what is back on sale, on pages that search engines and answer engines can find and cite, in the languages of each affected market. The healthcare professionals Nestlé names as its first audience are searchers too, and they tend to look for primary sources.
In 2023 I wrote that markets move on filings while reputation hardens on the results page. Nestlé has now put a figure on both halves of that sentence in a single quarter. The figure for the second half is the one still moving.